Portland, ORNCT01957267Now EnrollingIRB Ready

Glaucoma Clinical Trial in Portland, OR

Access cutting-edge glaucoma treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.

Sponsored by Oregon Health and Science University

Quick Self-Assessment

See if you qualify for this Portland location

Preparing your pre-screening questions…

Expert Care in Portland

Access glaucoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related glaucoma treatment provided free

Apply for This Portland Location

Check if you qualify for this glaucoma clinical trial in Portland, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Portland

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Portland site if eligible
  4. 4Begin participation

About This Glaucoma Study in Portland

The specific aims of the clinical studies are to: * Develop a directional high-resolution OCT and OCT angiography prototype to improve imaging of structure and perfusion. * Validate wide-field OCT and OCT angiography parameters to improve early glaucoma detection. * Simulate visual field results by combining structural and angiography OCT data. * Assess abilities of above technologies and OCT-derived parameters on predicting glaucoma detection, conversion, and progression.

Sponsor: Oregon Health and Science University

Who Can Participate

Inclusion Criteria

Normal Subjects (both eyes must meet all criteria)
No history or evidence of retinal pathology or glaucoma
Normal Humphrey 24-2 VF: A mean defect (MD), corrected pattern standard deviation (CPSD) within 95% limits of normal reference, and glaucoma hemifield test (GHT) within normal limits (97%).
Intraocular pressure \< 21 mm Hg
Central corneal pachymetry \> 500 microns
No chronic ocular or systemic corticosteroid use
Open angle (gonioscopy must show 75% or more of the angle to be Grade 2 or more by Shaffer's grading system)
Normal appearing ONH and NFL: vertical and horizontal cup/disc ratio (CDR) ≤ 0.5 and intact neuroretinal rim without peripapillary hemorrhages, notches, localized pallor, or NFL defect
Symmetric ONH between left and right eyes: CDR difference \< 0.2 in both vertical and horizontal dimensions Inclusion criteria: Glaucoma Group
ONH or NFL defect visible on slit-lamp biomicroscopy defined as one of following:
diffuse or localized thinning of the rim
disc (splinter) hemorrhage
notch in the rim
vertical cup/disc ratio greater than the fellow eye by \> 0.2
Presence or absence of VF defects as measured by Humphrey SITA 24-2 VF.

Exclusion Criteria

Best-corrected visual acuity less than 20/40
Age \< 40 or \>85 years
Refractive error of \> +3.00 D or \< -7.00 D
Previous intraocular surgery except for uncomplicated keratorefractive surgery and cataract extraction with posterior chamber intraocular lens implantation
Diabetic retinopathy
Other diseases that may cause VF loss or optic disc abnormalities
Inability to clinically view or photograph the optic discs due to media opacity or poorly dilating pupil
Inability to perform reliably on automated VF testing
Life-threatening or debilitating illness making it unlikely patient could successfully complete the study.
Refusal of informed consent or of commitment to the full length of the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Portland?

Yes, this clinical trial (NCT01957267) has an active research site in Portland, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Glaucoma Treatment Options in Portland, OR

If you're searching for glaucoma treatment options in Portland, OR, this clinical trial (NCT01957267) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all glaucoma clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Portland, OR

See all ulcerative colitis clinical trials recruiting in Portland — not just this study.

Browse Ulcerative Colitis Trials in Portland →

Browse More Trials by Condition

Ulcerative Colitis TrialsGlaucoma TrialsAll Conditions →

Ready to Join in Portland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Portland, OR